Genmab — September 2022
-
Godmorgen.
-
Godmorgen.
-
Asien: Negativ kvartalsafslutning uden mange lyspunkter https://www.proinvestor.com/investornyt/885084/asien-negativ-kvartalsafslutning-uden-mange-lyspunkter-ny
-
Fredagens aviser med Carlsberg, Vestjysk Bank og Bavarian Nordic https://www.proinvestor.com/investornyt/885079/fredagens-aviser-med-carlsberg-vestjysk-bank-og-bavarian-nordic
-
Markerer USD top begyndelsen til finansiel krise, investorkapitulation eller "opturstræthed" https://www.proinvestor.com/boards/106534
-
Første bispecifikke antistof mod myelomatose godkendt i EU
Europa-Kommissionen har givet en betinget markedsføringstilladelse til det bespecifikke antistof Tecvayli (teclistamab) som monoterapi til behandling af voksne patienter med recidiverende og refraktær myelomatose (RRMM).
(haematologisktidsskrift.dk)
-
Darzalex-tilføjelse øger PFS ved nydiagnosticeret, transplantationsberettiget myelomatose
Der er en fordel af at tilføje Darzalex (daratumumab) til RVd (Revlimid (lenalidomid), Velcade (bortezomib), dexamethason) ved behandling af nydiagnosticerede, transplantationsberettigede myelomatosepatienter.
(haematologisktidsskrift.dk)
-
Fredagens aktier: Cykliske aktier gjorde comeback sammen med C25 https://www.proinvestor.com/investornyt/885243/fredagens-aktier-cykliske-aktier-gjorde-comeback-sammen-med-c25
-
USA/lukning: Nyt kvartalsdyk giver dårligste stime siden finanskrisen https://www.proinvestor.com/investornyt/885357/usa-lukning-nyt-kvartalsdyk-giver-darligste-stime-siden-finanskrisen
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind